VCI Global Regains Compliance with Nasdaq Minimum Bid Price Rule 26-11-2024, 21:09

BetterCaths Coalition Assists Rep. Josh Turek in Designing 26-02-2023, 21:42

Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma 16-10-2023, 19:21